CACNA1E Gene

CACNA1E Gene

Overview

CACNA1E Gene

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">CACNA1E Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>CACNA1E</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Calcium Voltage-Gated Channel Subunit Alpha1 E</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>1q25.1</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>777</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000198004</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>Q15878</td>
</tr>
<tr>
<td class="label">Disease</td>
<td>Association Type</td>
</tr>
<tr>
<td class="label">[Alzheimer's Disease](/diseases/alzheimers-disease)</td>
<td>Risk Modulator</td>
</tr>
<tr>
<td class="label">[Parkinson's Disease](/diseases/parkinsons-disease)</td>
<td>Risk Modulator</td>
</tr>
<tr>
<td class="label">Epilepsy</td>
<td>Causative</td>
</tr>
<tr>
<td class="label">Bipolar Disorder</td>
<td>Risk Modifier</td>
</tr>
<tr>
<td class="label">Intellectual Disability</td>
<td>Causative</td>
</tr>
<tr>
<td class="label">Drug/Compound</td>
<td>Type</td>
</tr>
<tr>
<td class="label">SNX-482</td>
<td>Peptide toxin</td>
</tr>
<tr>
<td class="label">Y5AA-311N</td>
<td>Small molecule</td>
</tr>
<tr>
<td class="label">Ethosuximide</td>
<td>Small molecule</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">18 edges</a></td>
</tr>
</table>

Cacna1E Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Introduction

Cacna1E Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes. [@yasuda2003]

Gene Overview

CACNA1E (Calcium Voltage-Gated Channel Subunit Alpha1 E) encodes the α1E subunit of voltage-gated calcium channels, forming the pore of the R-type (CaV2.3) calcium channel. [@smith2019]

Basic Information

Function

The CACNA1E gene encodes the α1E subunit that forms the pore of the R-type voltage-gated calcium channel (CaV2.3). This channel is characterized by:

• High-voltage activation: Activates at relatively depolarized membrane potentials
• Rapid inactivation: Shows both fast and slow inactivation kinetics
• neuronal expression: Highly expressed in hippocampal [neurons](/entities/neurons), cerebellar granule cells, and various cortical regions
• Dendritic localization: Primarily located on dendritic shafts and spines where it contributes to calcium influx during backpropagating action potentials

• Dendritic calcium signaling and synaptic integration
• Triggering neurotransmitter release at excitatory synapses
• Gene expression regulation via calcium-dependent signaling pathways
• Regulation of neuronal excitability and firing patterns

Disease Associations

Key Mutations

• R857Q: Gain-of-function mutation causing epileptic encephalopathy
• I1168V: Variant associated with epilepsy risk
• G407R: De novo mutation causingID

Expression Pattern

CACNA1E shows region-specific expression in the brain:

• [Hippocampus](/brain-regions/hippocampus): High expression in CA1-CA3 pyramidal neurons
• Cerebellum: Expressed in granule cells and Purkinje cells
• [Cortex](/brain-regions/cortex): Layer 2/3 and layer 5 pyramidal neurons
• Striatum: Medium spiny neurons
• Thalamus: Relay neurons

Therapeutic Targeting

R-type calcium channels are being explored as therapeutic targets:

Clinical Implications

• Neuroprotection: R-type channel blockers may protect against excitotoxicity in AD and PD
• Epilepsy treatment: Gain-of-function mutations may respond to channel blockers
• Cognitive enhancement: Modulating CaV2.3 may improve synaptic plasticity

Key Publications

See Also

• [Voltage-Gated Calcium Channels](/mechanisms/ion-channel-dysfunction-neurodegeneration))
• [Calcium Signaling in Neurodegeneration](/mechanisms/calcium-dysregulation)
• [Excitotoxicity](/mechanisms/excitotoxicity)
• [Synaptic Dysfunction Pathway](/mechanisms/synaptic-dysfunction-pathway)
• [Cav2.3 Protein](/proteins/cav2-3-protein)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Epilepsy](/diseases/epilepsy)

External Links

• [NCBI Gene: CACNA1E](https://www.ncbi.nlm.nih.gov/gene/777)
• [UniProt: CACNA1E](https://www.uniprot.org/uniprot/Q15878)
• [Allen Brain Atlas: CACNA1E](https://human.brain-map.org/microarray/search/show?search_term=CACNA1E)
• [OMIM: CACNA1E](https://www.omim.org/entry/601005)

Overview

Cacna1E Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Background

The study of Cacna1E Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

Pathway Diagram

The following diagram shows the key molecular relationships involving CACNA1E Gene discovered through SciDEX knowledge graph analysis: